biguanides has been researched along with Glaucoma, Suspect in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khawaja, AP | 1 |
| Chan, MP | 1 |
| Broadway, DC | 1 |
| Garway-Heath, DF | 1 |
| Luben, R | 1 |
| Yip, JL | 1 |
| Hayat, S | 1 |
| Wareham, NJ | 1 |
| Khaw, KT | 1 |
| Foster, PJ | 1 |
1 other study available for biguanides and Glaucoma, Suspect
| Article | Year |
|---|---|
Systemic medication and intraocular pressure in a British population: the EPIC-Norfolk Eye Study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aspirin; Biguanides; Blood Pressure; Body Mass | 2014 |